Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Business

Nigeria, others to receive first-ever HIV generic drug for babies in the first half of 2021

Adeyemi Adebayo by Adeyemi Adebayo
December 2, 2020
in Business
Nigeria, others to receive first-ever HIV generic drug for babies in the first half of 2021
Share on FacebookShare on TwitterShare on Linkedin

Nigeria and six other African countries will receive the first-ever HIV generic drug for babies in the first half of 2021.

This is according to UNITAID – global health initiative that works with partners to bring about innovations to prevent, diagnose, and treat major diseases in low-and middle-income countries, with an emphasis on tuberculosis, malaria, and HIV/AIDS, and its deadly co-infections.

UNITAID noted that the drug, a strawberry-flavoured tablet, is the first generic pediatric version of a key anti-retroviral available, even for babies, and will be rolled out in African countries in 2021.

RelatedPosts

How to reduce your electricity bill in Lagos

CBN’s forex policies: Timeline between Covid-2020 and 2021

READ: COVID-19: NCDC issues travel advisory for the yuletide season

What you should know

  • According to UNITAID, about 1.7 million children worldwide live with HIV, but only half receive any treatment – often hard to administer due to the bitter taste or incorrectly dosed by crushing adult pills.
  • About 100,000 children die of AIDS annually.
  • The first-line HIV treatment is recommended by the World Health Organization (WHO) from the age of four weeks and 3 kilos (6.6 pounds), but it had been out of reach for babies because of the lack of appropriate formulations.
  • UNITAID and the Clinton Health Access Initiative have reached a pricing agreement with the generic drug makers Viatris and Macleods for the dispersible pediatric formulation of dolutegravir (DTG).

In this context, UNITAID maintained “the estimated cost for combination therapy will now be some $120 for a child’s annual treatment, against $480 currently, making it a ‘game-changer’ for poorer countries.”

News continues after this ad


READ: Covid-19: Unilever Nigeria suffers 40% revenue loss

What they are saying

UNITAID spokesman, Herve Verhoosel, told Geneva news briefing that, “For many of those children, the HIV virus is not suppressed due in part to lack of availability of effective drugs that are palatable and properly adapted for them.”

News continues after this ad


According to Verhoosel, “Benin, Kenya, Malawi, Nigeria, Uganda and Zimbabwe are due to receive the first tablets in the first half of 2021.”

READ: Nigeria’s inflation rate to moderate by first half of next year

Related

Tags: HIV generic drugNigeria NewsUNITAID

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Mega Millions
Hot forex
Cornerstone
Polaris Bank
Access Bank
Bankers Committee
First bank


FCMB




    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • Most valuable companies in Nigeria as of June 2022
    • Investment strategies you should adopt in your 20s
    • Nigerian airline passengers to experience flight delays for the next 3 months

    Follow us on social media:

    Recent News

    exchange rate crisis

    Most valuable companies in Nigeria as of June 2022

    July 7, 2022
    Investment strategies you should adopt in your 20s

    Investment strategies you should adopt in your 20s

    July 7, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com